Finally, an on-demand source of mutation characterized tumor FFPE tissue samples

FFPE tissue blocks that have been sequenced for genetic mutations.

Precision medicine demands precision research. In other words, researchers require very specific human biospecimens to develop new techniques, tests, diagnostics, and treatments. Sadly, such samples are in sparse supply and finding them can be quite challenging and painful. Supply comes nowhere close to meeting demand. Genetic signatures are the quintessence of specificity in human biospecimens…

Read More

Keep your research on track

Although the coronavirus pandemic has turned our worlds upside down, it’s important for you to land on your feet. We want to help. If you work in a medical research organization, you may have or slowed or paused projects because of social distancing, or you may have pivoted to accelerate work on coronavirus treatments, tests or vaccines.

Read More

Let’s stick to the mission

When research is on hold, so, in some cases, are patients’ hopes for relief. That’s why it’s important to remember that even if you, as a researcher, are separated from your work, you can continue valuable activities in the background, e.g., project design, planning and preparation.

Read More

Eight questions with Benjamin Bielak

Veteran health care informatics expert Benjamin Bielak recently joined iSpecimen as its first Chief Information Officer. He is the subject of our latest Q&A… 1. The iSpecimen Marketplace is often compared to eBay or Amazon for clarity, but it’s certainly more complicated than that. What are the biggest technology challenges of an online marketplace not…

Read More

Fresh blood samples from clinic to out-of-state lab. Every day, in a two-hour window.

September Specimen Spotlight There are two ways for research organizations to procure human biospecimens, broadly speaking: Order them from existing inventories. Have them collected explicitly for the task at hand. We offer both. Although our iSpecimen Marketplace is optimized for procurement from existing inventories around the world, we often arrange prospective custom collection of new biospecimens…

Read More

January Specimen Spotlight: prospectively collecting ovarian tumor tissue for longitudinal study

Although you can learn a lot from cancerous tissue, you can learn even more when you have patient data to put the biology in context. That’s why one iSpecimen client, a U.S. cancer research and diagnostic company, recently ordered longitudinal patient information from iSpecimen to complement its request for ovarian cancer tissue specimens. The company…

Read More

June Specimen Spotlight: improving early detection of Lyme disease

Lyme disease, a tick-borne infection diagnosed in roughly 330,000 Americans every year, becomes a heightened concern in June and July, especially for people in the Northeast and upper Midwest, where the disease is concentrated. Early diagnosis and treatment with antibiotics, however, usually means a rapid and complete recovery. Our June Specimen Spotlight features a set of…

Read More